These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 15849477

  • 1. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
    Boaz M, Iuliano L, Himmelfarb J, Matas Z, Micheletta F, McMonagle E, Friedman V, Natoli S, Gvirtz G, Biro A, Smetana S, Sabo G, Gafter U, Weinstein T.
    Nephron Clin Pract; 2005; 100(4):c111-9. PubMed ID: 15849477
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
    Arca M, Natoli S, Micheletta F, Riggi S, Di Angelantonio E, Montali A, Antonini TM, Antonini R, Diczfalusy U, Iuliano L.
    Free Radic Biol Med; 2007 Mar 01; 42(5):698-705. PubMed ID: 17291993
    [Abstract] [Full Text] [Related]

  • 3. Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque.
    Micheletta F, Natoli S, Misuraca M, Sbarigia E, Diczfalusy U, Iuliano L.
    Arterioscler Thromb Vasc Biol; 2004 Jan 01; 24(1):136-40. PubMed ID: 14592846
    [Abstract] [Full Text] [Related]

  • 4. In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress.
    Larsson H, Böttiger Y, Iuliano L, Diczfalusy U.
    Free Radic Biol Med; 2007 Sep 01; 43(5):695-701. PubMed ID: 17664133
    [Abstract] [Full Text] [Related]

  • 5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr 01; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 6. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul 01; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 7. Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients.
    Arciello M, Petta S, Leoni V, Iannucci G, Labbadia G, Cammà C, Craxì A, Balsano C.
    Dig Liver Dis; 2012 Mar 01; 44(3):245-50. PubMed ID: 22154950
    [Abstract] [Full Text] [Related]

  • 8. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
    Kirmizis D, Papagianni A, Belechri AM, Memmos D.
    Nephrol Dial Transplant; 2011 Jul 01; 26(7):2296-301. PubMed ID: 21127134
    [Abstract] [Full Text] [Related]

  • 9. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M, Dusilova-Sulkova S, Kalousova M, Soukupova J, Zima T, Mikova D, Malbohan IM, Bartunkova J.
    Ren Fail; 2006 Jul 01; 28(5):395-9. PubMed ID: 16825088
    [Abstract] [Full Text] [Related]

  • 10. High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation.
    Corradini SG, Micheletta F, Natoli S, Iappelli M, Di Angelantonio E, De Marco R, Elisei W, Siciliano M, Rossi M, Berloco P, Attili AF, Diczfalusy U, Iuliano L.
    Liver Transpl; 2005 Dec 01; 11(12):1494-504. PubMed ID: 16258953
    [Abstract] [Full Text] [Related]

  • 11. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L, Kalousová M, Soukupová J, Sulková S, Merta M, Jelínková E, Horejsí M, Srámek P, Malbohan I, Mikulíková L, Tesar V, Zima T.
    Kidney Blood Press Res; 2004 Dec 01; 27(2):88-95. PubMed ID: 14739577
    [Abstract] [Full Text] [Related]

  • 12. Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
    Diepeveen SH, Verhoeven GH, van der Palen J, Dikkeschei BL, van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF.
    Nephron Clin Pract; 2004 Dec 01; 98(1):c3-7. PubMed ID: 15361698
    [Abstract] [Full Text] [Related]

  • 13. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AA.
    Ann Nutr Metab; 2009 Dec 01; 55(4):309-16. PubMed ID: 19828941
    [Abstract] [Full Text] [Related]

  • 14. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N, Senécal L, Dupuy AM, Jaussent I, Delcourt C, Leray H, Rafaelsen S, Bosc JY, Maurice F, Canaud B, Cristol JP.
    Hemodial Int; 2005 Apr 01; 9(2):159-68. PubMed ID: 16191065
    [Abstract] [Full Text] [Related]

  • 15. Oxysterols are increased in plasma of end-stage renal disease patients.
    Siems W, Quast S, Peter D, Augustin W, Carluccio F, Grune T, Sevanian A, Hampl H, Wiswedel I.
    Kidney Blood Press Res; 2005 Apr 01; 28(5-6):302-6. PubMed ID: 16534225
    [Abstract] [Full Text] [Related]

  • 16. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
    Fellah H, Feki M, Souissi M, Ghorbel H, Ben Abdallah T, Massy Z, Hedhili A, Ben Maiz H, Lacour B, Kaabachi N, Mebazaa A.
    Tunis Med; 2006 Nov 01; 84(11):724-9. PubMed ID: 17294900
    [Abstract] [Full Text] [Related]

  • 17. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients.
    Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM, Cicekler H, Anil M, Ozbek O, Selcuk NY, Yeksan M, Turk S.
    Ren Fail; 2012 Nov 01; 34(10):1229-37. PubMed ID: 23025491
    [Abstract] [Full Text] [Related]

  • 18. Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease.
    Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Carvalho AB, Draibe SA, Canziani ME.
    Nephron Clin Pract; 2010 Nov 01; 115(3):c189-94. PubMed ID: 20413996
    [Abstract] [Full Text] [Related]

  • 19. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
    Xu Y, Ding X, Zou J, Liu Z, Jiang S, Xu S, Shen B, Chen Y, Shan Y, Cao X.
    Ren Fail; 2011 Nov 01; 33(10):998-1004. PubMed ID: 22013933
    [Abstract] [Full Text] [Related]

  • 20. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients.
    Ari E, Kaya Y, Demir H, Cebi A, Alp HH, Bakan E, Odabasi D, Keskin S.
    Hemodial Int; 2011 Oct 01; 15(4):453-9. PubMed ID: 22111813
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.